Documente Academic
Documente Profesional
Documente Cultură
2016;66(5):505---512
REVISTA
BRASILEIRA DE
ANESTESIOLOGIA Publicação Oficial da Sociedade Brasileira de Anestesiologia
www.sba.com.br
REVIEW ARTICLE
a
Departamento de Anestesiologia e Cirurgia, Universidade Federal da Bahia (UFBA), Salvador, BA, Brazil
b
Sociedade Brasileira para o Estudo da Dor, São Paulo, SP, Brazil
c
Ambulatório de Dor, Complexo Universitário Prof. Edgar Santos, Salvador, BA, Brazil
d
Departamento de Anestesiologia, Dor e Terapia Intensiva, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil
e
Anestesiologia, Complexo Universitário Hospital Edgar Santos, Universidade Federal da Bahia (UFBA), Salvador, BA, Brazil
f
Faculdade de Medicina, Universidade Federal da Bahia (UFBA), Salvador, BA, Brazil
g
Liga Acadêmica para o Estudo da Dor, Salvador, BA, Brazil
h
Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil
KEYWORDS Abstract
Postoperative chronic Background and objectives: Postoperative persistent chronic pain (POCP) is a serious health
pain; problem, disabling, undermining the quality of life of affected patients. Although more studies
Analgesia; and research have addressed the possible mechanisms of the evolution from acute pain to
Prevention; chronic postoperatively, there are still no consistent data about the risk factors and prevention.
Treatment; This article aims to bring what is in the panorama of the current literature available.
Risk factors Content: This review describes the definition, risk factors, and mechanisms of POCD, its pre-
vention and treatment. The main drugs and techniques are exposed comprehensively.
Conclusion: Postoperative persistent chronic pain is a complex and still unclear etiology entity,
which interferes heavily in the life of the subject. Neuropathic pain resulting from surgical
trauma is still the most common expression of this entity. Techniques to prevent nerve injury
are recommended and should be used whenever possible. Despite efforts to understand and
select risk patients, the management and prevention of this syndrome remain challenging and
inappropriate.
© 2015 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
夽 Instituição: Universidade Federal da Bahia, Salvador, BA, Brasil; Universidade Federal de São Paulo, São Paulo, SP, Brasil.
∗ Corresponding author.
E-mail: riokoks.dcir@epm.br (R.K. Sakata).
http://dx.doi.org/10.1016/j.bjane.2014.12.005
0104-0014/© 2015 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
506 D.C. Kraychete et al.
PALAVRAS-CHAVE Dor crônica persistente pós-operatória: o que sabemos sobre prevenção, fatores
Dor crônica de risco e tratamento?
pós-operatória;
Resumo
Analgesia;
Justificativa e objetivos: A dor crônica persistente pós-operatória (DCPO) constitui um grave
Prevenção;
problema de saúde, incapacitante, mina a qualidade de vida dos pacientes acometidos. Apesar
Tratamento;
de mais estudos e pesquisas terem sido desenvolvidos a respeito dos possíveis mecanismos da
Fatores de risco
evolução da dor aguda para dor crônica pós-operatória, ainda não existem dados consistentes
a respeito de seus fatores de risco e prevenção. Este artigo se propõe a trazer o que há no
panorama da literatura atual disponível.
Conteúdo: Esta revisão descreve a definição, os fatores de risco e os mecanismos da DCPO, sua
prevenção e seus tratamentos. Os principais medicamentos e técnicas são expostos de forma
compreensiva.
Conclusão: A dor crônica persistente pós-operatória é uma entidade complexa e de etiolo-
gia ainda não esclarecida, que interfere intensamente na vida do sujeito. A dor neuropática
decorrente do trauma cirúrgico ainda é a expressão mais comum dessa entidade. Técnicas que
evitem a lesão de nervos estão recomendadas e devem ser usadas sempre que possível. Apesar
dos esforços para entender e selecionar os pacientes de risco, o manuseio e a prevenção dessa
síndrome continuam desafiantes e inapropriados.
© 2015 Sociedade Brasileira de Anestesiologia. Publicado por Elsevier Editora Ltda. Este é um
artigo Open Access sob uma licença CC BY-NC-ND (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
22. Burke S, Shorten GD. When pain after surgery doesn’t go away. 44. Sinner B, Graf BM. Ketamine. Handb Exp Pharmacol.
Biochem Soc Trans. 2009;37 Pt 1:318---22. 2008;182:313---33.
23. Yan S, Wu N, Xiong HC, et al. Effect of bilateral intercostal 45. De Kock M, Lavand’homme P, Waterloos H. ‘‘Balanced analge-
nerve protection on post-thoracotomy pain relief: a prospec- sia’’ in the perioperative period: is there a place for ketamine?
tive single-blinded randomized study. Zhonghua Yi Xue Za Zhi. Pain. 2001;92:373---80.
2008;88:597---601. 46. Detweiler DJ, Eisenach JC, Tong C, et al. A cholinergic
24. Hakeem A, Shanmugam V. Inguinodynia following Lichtenstein interaction in alpha 2 adrenoceptor-mediated antinoci-
tension-free hernia repair: a review. World J Gastroenterol. ception in sheep. J Pharmacol Exp Ther. 1993;265:
2011;17:1791---6. 536---42.
25. Katz J, Seltzer Z. Transition from acute to chronic postsurgical 47. Bonnet F, Buisson VB, Francois Y, et al. Effects of oral and sub-
pain: risk factors and protective factors. Expert Rev Neurother. arachnoid clonidine on spinal anesthesia with bupivacaine. Reg
2009;9:723---44. Anesth. 1990;15:211---4.
26. Sadatsune EJ, Leal PC, Clivatti J, et al. Dor crônica pós- 48. Eisenach JC, De Kock M, Klimscha W. Alpha(2)-adrenergic
operatória: fisiopatologia, fatores de risco e prevenção. Rev Dor. agonists for regional anesthesia. A clinical review
2011;12:58---63. of clonidine (1984---1995). Anesthesiology. 1996;85:
27. Janssen KJ, Kalkman CJ, Grobbee DE, et al. The risk of severe 655---74.
postoperative pain: modification and validation of a clinical 49. Watkins LR, Maier SF. Glia: a novel drug discovery target for
prediction rule. Anesth Analg. 2008;107:1330---9. clinical pain. Nat Rev Drug Discov. 2003;2:973---85.
28. Finnerup NB, Sindrup SH, Jensen TS. The evidence for 50. Reuben SS. Preventing the development of complex
pharmacological treatment of neuropathic pain. Pain. regional pain syndrome after surgery. Anesthesiology.
2010;150:573---81. 2004;101:1215---24.
29. Wong K, Phelan R, Kalso E, et al. Antidepressant drugs for 51. Chidambaran V, Ngamprasertwong P, Vinks AA, et al. Phar-
prevention of acute and chronic postsurgical pain: early evi- macogenetics and anesthetic drugs. Curr Clin Pharmacol.
dence and recommended future directions. Anesthesiology. 2012;7:78---101.
2014;121:591---608. 52. Yanagidate F, Strichartz GR. Local anesthetics. Handb Exp
30. Auerbach AD, Vittinghoff E, Maselli J, et al. Perioperative Pharmacol. 2007:95---127.
use of selective serotonin reuptake inhibitors and risks for 53. Sinclair R, Eriksson AS, Gretzer C, et al. Inhibitory effects of
adverse outcomes of surgery. JAMA Intern Med. 2013;173: amide local anaesthetics on stimulus-induced human leukocyte
1075---81. metabolic activation LTB4 release and IL-1 secretion in vitro.
31. Seitz DP, Bell CM, Gill SS, et al. Risk of perioperative Acta Anaesthesiol Scand. 1993;37:159---65.
blood transfusions and postoperative complications associated 54. Goldstein IM, Lind S, Hoffstein S, et al. Influence of local anes-
with serotonergic antidepressants in older adults undergo- thetics upon human polymorphonuclear leukocyte function in
ing hip fracture surgery. J Clin Psychopharmacol. 2013;33: vitro. Reduction of lysosomal enzyme release and superoxide
790---8. anion production. J Exp Med. 1977;146:483---94.
32. Weinrieb RM, Auriacombe M, Lynch KG, et al. Selective sero- 55. Møiniche S, Kehlet H, Dahl JB. A qualitative and quantitative
tonin re-uptake inhibitors and the risk of bleeding. Expert Opin systematic review of preemptive analgesia for postoperative
Drug Saf. 2005;4:337---44. pain relief: the role of timing of analgesia. Anesthesiology.
33. Sills GJ. The mechanisms of action of gabapentin and prega- 2002;96:725---41.
balin. Curr Opin Pharmacol. 2006;6:108---13. 56. Møiniche S, Mikkelsen S, Wetterslev J, et al. A qualitative
34. Gidal BE. New and emerging treatment options for neuropathic systematic review of incisional local anaesthesia for postop-
pain. Am J Manag Care. 2006;12 9 Suppl.:S269---78. erative pain relief after abdominal operations. Br J Anaesth.
35. Taylor CP, Gee NS, Su TZ, et al. A summary of mecha- 1998;81:377---83.
nistic hypotheses of gabapentin pharmacology. Epilepsy Res. 57. Hannibal K, Galatius H, Hansen A, et al. Preoperative
1998;29:233---49. wound infiltration with bupivacaine reduces early and
36. Dahl JB, Mathiesen O, Møiniche S. ‘‘Protective premedication’’: late opioid requirement after hysterectomy. Anesth Analg.
an option with gabapentin and related drugs? A review of 1996;83:376---81.
gabapentin and pregabalin in the treatment of post-operative 58. Lombardi AV Jr, Berend KR, Mallory TH, et al. Soft tissue and
pain. Acta Anaesthesiol Scand. 2004;48:1130---6. intra-articular injection of bupivacaine, epinephrine, and mor-
37. Sills GJ. Not another gabapentin mechanism! Epilepsy Curr. phine has a beneficial effect after total knee arthroplasty. Clin
2005;5:75---7. Orthop Relat Res. 2004:125---30.
38. Fassoulaki A, Triga A, Melemeni A, et al. Multimodal analge- 59. Singh K, Phillips FM, Kuo E, et al. A prospective, randomized,
sia with gabapentin and local anesthetics prevents acute and double-blind study of the efficacy of postoperative continuous
chronic pain after breast surgery for cancer. Anesth Analg. local anesthetic infusion at the iliac crest bone graft site after
2005;101:1427---32. posterior spinal arthrodesis: a minimum of 4-year follow-up.
39. Brogly N, Wattier JM, Andrieu G, et al. Gabapentin attenuates Spine (Phila Pa 1976). 2007;32:2790---6.
late but not early postoperative pain after thyroidec- 60. Ballieul RJ, Jacobs TF, Herregods S, et al. The peri-operative use
tomy with superficial cervical plexus block. Anesth Analg. of intra-articular local anesthetics: a review. Acta Anaesthesiol
2008;107:1720---5. Belg. 2009;60:101---8.
40. Clivatti J, Sakata RK, Issy AM. Review of the use of gabapentin 61. Shum CF, Lo NN, Yeo SJ, et al. Continuous femoral nerve block
in the control of postoperative pain. Rev Bras Anestesiol. in total knee arthroplasty: immediate and two-year outcomes.
2009;59:87---98. J Arthroplasty. 2009;24:204---9.
41. Ben-Menachem E. Pregabalin pharmacology and its relevance to 62. Klein SM. Beyond the hospital: continuous peripheral nerve
clinical practice. Epilepsia. 2004;45 Suppl. 6:13---8. blocks at home. Anesthesiology. 2002;96:1283---5.
42. Rowbotham DJ. Gabapentin: a new drug for postoperative pain? 63. Klein SM, Pietrobon R, Nielsen KC, et al. Peripheral nerve
Br J Anaesth. 2006;96:152---5. blockade with long-acting local anesthetics: a survey of the
43. Hirota K, Lambert DG. Ketamine: its mechanism(s) of action and Society for Ambulatory Anesthesia. Anesth Analg. 2002;94:
unusual clinical uses. Br J Anaesth. 1996;77:441---4. 71---6.
512 D.C. Kraychete et al.
64. Klein SM, Evans H, Nielsen KC, et al. Peripheral nerve anaesthesia: results from overview of randomised trials. BMJ.
block techniques for ambulatory surgery. Anesth Analg. 2000;321:1493.
2005;101:1663---76. 66. Obata H, Saito S, Fujita N, et al. Epidural block with mepiva-
65. Rodgers A, Walker N, Schug S, et al. Reduction of post- caine before surgery reduces long-term post-thoracotomy pain.
operative mortality and morbidity with epidural or spinal Can J Anaesth. 1999;46:1127---32.